In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in need of palliative support in an accurate and needs-based manner, as recommended in guidelines. In the context of Germany and Switzerland, a distinction is made between general palliative care (APV) and specialized palliative care (SPV).
Autoren
- Prof. Dr. med. Birgitt van Oorschot
- Dr. med. Carmen Roch
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Gestational diabetes
Significant CVD prevention through five lifestyle factors
- Modern therapeutic approaches for melanoma
Innovative strategies to overcome immunotherapy resistance
- Irritable Bowel Syndrome
“Best practice” recommendations for step-by-step clarification and stage-adapted therapy
- Nutritional supplements and cognition
5-HTP: The serotonin booster for cognition in old age
- Pulmonary hypertension
PH and lung diseases
- CRC, AML and melanoma in focus
Molecular mechanisms of tumor plasticity
- Friedreich's ataxia
Interim analyses of the PROFA study show “Unmet needs”
- Hepatitis B prophylaxis